2014, Number 2
<< Back Next >>
Dermatología Cosmética, Médica y Quirúrgica 2014; 12 (2)
Seborrheic dermatitis: A review
Medina CDE
Language: Spanish
References: 34
Page: 135-141
PDF size: 212.48 Kb.
ABSTRACT
Seborrheic dermatitis is a chronic inflammatory, erythrosquamous
disorder affecting scalp, face, torso and/or groin. It is
present in all age groups and often associated with immunosuppression
and Parkinson’s disease. This is a review of existing
literature.
REFERENCES
Falabella FR, Victoria Ch J. Barona CMI, Dominguez SL “Acné vulgar”, en: Fundamentos de Medicina Dermatología, 6ª Edición. Bogotá Colombia Corporación para Investigaciones Biológicas, 2002, pp. 38-47
Gupta AK, Bluhm R. “Seborrheic dermatitis”. J Eur Acad Dermatol Venereol 2004; 18: 13-26.
Begbrant IM, Johansson S,Robbins D, Scheynus A, Faergemann J, Söderström T. “An immunological study in patients with seborrheic dermatitis”. Clin Exp Dermatol 1991; 16: 331-338.
Collett E, Hsieh M, Ambjørn M, Law J, Dutz J, et al. “A novel T cell receptor transgenic animal model of seborrheic dermatitis-like skin disease”. J Invest Dermatol 2005; 124: 151-159.
Nippon Ishinkin Gakkai Zasshi. “Malassezia species in patients with seborrheic dermatitis and atopic dermatitis”. Jpn J Med Mycol 2005; 46: 163-167.
Difonzo EM, Faggi E. “Skin diseases associated with Malassezia species in humans. Clinical features and diagnostic criteria”. Parassitologìa 2008;50:69-71
Gupta AK, Kohli Y, Summerbell RC, Faergemann J. “Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses”. Med Mycol 2001; 39: 243-251.
Nakabayashi A, Sei Y, Guillot J. “Identification of Malassezia species isolated from patients with seborrheic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects”. Med Mycol 2000;38:337-341.
Hernández Hernández F, Méndez Tovar LJ, Bazán Mora E, Arévalo López A, Valera Bermejo A, López Martínez R. “Species of Malassezia associated with various dermatoses and healthy skin in the Mexican population”. Rev Iberoam Micol 2003; 20: 141-144.
Mirza SH, Rehman H, Khan MA. “Role of Malassezia yeast (Pityrosporum) in seborrhoeic dermatitis (SD)”. J Coll Physicians Surg Pak 2005; 15: 771-773.
Rendic E, Díaz C, Fich F. “Characterization of species of the gender Malassezia in patients with seborrheic dermatitis and subjets without skin lesions”. Rev. Med Chil 2003;131:1295-1300.
Wikler JR, Nieboer C, Willemze R. “Quantitative skin cultures of Pityrosporum yeasts in patients seropositive for the human immunodeficiency virus with and without seborrheic dermatitis”. J Am Acad Dermatol 1992; 27: 37-39.
Bergbrant IM “Seborrheic dermatitis and Pityrosporum ovale: cultural, immunological and clinical studies”. Acta Derm Venereol Suppl (Stockh) 1991; 167: 1-36.
Ruíz MR, LopezMR, Perez ChEL, Rocio CL, Tamayo L, “Pityrosporum ovale in infantile seborrheic dermatitis”. Pediatr Dermatol 1989; 6: 16-20.
Celis AM, Cepero de García MC, “Polimorfismos genéticos de aislamiento de Malassezia spp”. Biomédica 2005; 25: 481-487.
Crespo-Erchiga V, Gómez-Moyano E, Crespo M, “Pitiriasis versicolor y las levaduras del género Malassezia”. Actas Dermo-sifiliográficas 2008; 99: 764-771.
Picardi A, Abeni D. “Stressful life events and skin diseases: disentangling evidence from myth”. Psychother Psychosom. 2001; 70: 118-136.
Misery L, Touboul S, Vinçot C, Dutray S, Rolland-Jacob G, Consoli SG, Farcet Y, et al. “Pour le Groupe Psychodermatologie. Stress and seborrheic dermatitis”. Ann Dermatol Venereol 2007; 134: 833-837.
Peyrí J, Lleonart M, Grupo español del Estudio SEBDERM. “Clinical and therapeutic profile and quality of life of patients with seborrheic dermatitis”. Actas Dermosifiliogr 2007; 98: 476-482.
Moehrle M, Dennenmoser B, Schlagenhauff B, Thomma S, Garbe C. “High prevalence of seborrheic dermatitis on the face and scalp in mountain guides”. Dermatology 2000; 201: 146-147.
Fischer M, Gemende I, MarschWC, Fischer PA. “Skin function and skin disorders in Parkinson’s disease”. J Neural Transm 2001; 108: 205-213.
Binder RL, Jonelis FJ. “Seborrheic dermatitis: a newly reported side effect of neuroleptics”. J Clin Psychiatry 1984; 45: 125-126.
Chatzikokkinou P, Sotiropoulos K, Katoulis A, Luzzati R, Trevisan G. “Seborrheic dermatitis an early and common skin manifestation in HIV patients”. Acta Dermatovenerol Croat 2008; 16: 226-230.
Nnoruka EN, Chukwuka JC, Anisuiba B. “Correlations of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progresión”. Int J Dermatol 2007; 46 (S2): 14-18.
Rigopoulos D, Paparizos V, Katsambas A. “Prevalence of dermatological disorders in Thai HIV-infected patients correlated with different CD4 lymphocyte count statuses: a note on 120 cases”. Clin Dermatol 2004; 22: 487-498.
Goh BK, Chan RK, Sen P, Theng CT, Tan HH, Wu YJ, et al. “Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts”. Int J Dermatol 2007; 46: 695-699.
Ippolito F, Passi S, Di Carlo A. “Is seborrheic dermatitis a clinical marker of HIV disease?” Minerva Ginecol 2000; 52 (S1): 54-58.
Ruiz MR, Tamayo SL, Duran McKC, Orozco CML “Dermatitis Seborreica”, en: Dermatología en la consulta pediátrica. Diagnóstico y tratamiento. 1ª Edición. México, Editores de textos mexicanos; 2008, p.p. 75-80
Huber-Spitzy V, Baumgartner I, Böhler-Sommeregger K, Grabner G “Blepharitis a diagnostic and therapeutic challenge. A report on 407 consecutives cases”. Graefes Arch Clin Exp Ophthalmol 1991; 229: 224-227.
Fonseca CE. Dermatitis seborreica del adulto. Salud Rural 1998; 15: 11 pp. 3-123.
Al-Waili NS. “Therapeutic and prophylactic effects of crude honey on chronic seborrheic dermatitis and dandruff”. Eur J Med Res 2001; 6: 306-308.
Schwartz RA, Janusz CA, Janniger CK. “Seborrheic dermatitis: an overview”. Am Fam Physician 2006; 74: 125-130.
Fonseca CE. “Pitiriasis y dermatitis seborreica del cuero cabelluda”. Piel 1994; 9: 23-28.
Gupta AK, Kogan N. “Seborrheic dermatitis: current treatment practices”. Expert Opin Pharmacother 2004; 5: 1755-1765.